All updates
All updates
today 33BioPharma Dive精选评分5252 BioPharma Dive精选评分6161 Viatris boosts pain drug portfolio with $1.7B buyout of Pacira
监管与产业动态评分3838 Signal or noise? > Ultragenyx cashes in Genglycos-derived priority review voucher for $210M - FirstWord Pharma >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #biotech #pharmaceutical #pharma #competitivemarketing
STAT News评分4040 STAT+: Roche goes beyond licensing in deal with Chinese biotech
中文产业新闻Chinese source评分4242 迪拓生物与罗氏达成合作，携手开发新型分子胶降解剂
中文产业新闻Chinese source评分3333 赛诺菲与再生元扩大抗体合作，共推四款2型炎症长效抗体药物
BioSpace精选评分6666 Big Pharma–backed Matchpoint scores $150M series B, advancing autoimmune asset
STAT News评分3737 STAT+: Pharmalittle: We’re reading about PhRMA suing Trump, biotech frustration over tariffs, and more
STAT News精选评分5151 STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines
中文产业新闻精选Chinese source评分7272 艾博生物与诺华达成超77.75亿美元授权及许可选择权协议，推进ABO2203及RNA疗法
中文产业新闻Chinese source评分4141 君合业绩丨君合助力迪拓生物与罗氏达成多靶点合作与授权协议
中文产业新闻Chinese source评分6060 亚虹医药将APL-1702欧洲及澳新土独家权益授权Theramex，总额超2.5亿美元
社区讨论（Reddit）评分6969 Novartis wagers almost $8B on a Chinese biotech’s RNA drugs
STAT News评分3939 STAT+: Why this startup is taking its AI to predict breast cancer risk directly to patients
监管与产业动态评分2020 Noom puts a spooky voice to the haunting threat of weight regain for GLP-1 users in new spot - Fierce Pharma
监管与产业动态评分5252 Stryker strikes up a new CEO in Spencer Stiles as Kevin Lobo moves upstairs - Fierce Biotech
监管与产业动态评分1919 Scaling psychedelics comes with uncertainty ‘baked into the sauce’ - Fierce Pharma
监管与产业动态评分3636 Halozyme stymies subcutaneous Keytruda launch in select European countries as Merck vows to fight patent claims - Fierce Pharma
中文产业新闻Chinese source评分6464 Forbion募得26亿美元新基金，资本寻找可落地生物科技公司
中文产业新闻Chinese source评分2121 思璞锐KRAS抑制剂授权默沙东，跨国药企密集锁定中国创新药
BioSpace评分4040 Q3 layoffs down YOY, with 90% fewer biopharma employees affected
中文产业新闻Chinese source评分6262 Enveda完成3.11亿美元E轮融资，用机器学习与代谢组学发现新化合物
中文产业新闻Chinese source评分2727 Cerevance口服solengepras 3期ARISE试验达主要终点；诺华BTK抑制剂获FDA批准新适应症
中文产业新闻Chinese source评分4141 迪拓生物与罗氏达成多靶点合作与授权协议，共同开发分子胶降解剂
中文产业新闻Chinese source评分6161 Forbion完成26亿美元新基金募资，礼来参投
中文产业新闻Chinese source评分4242 荷兰新锐RougeTx完成5800万美元A轮融资，开发HHT疾病修饰疗法RTX-001
中文产业新闻Chinese source评分5252 Ultragenyx以2.1亿美元出售罕见儿科疾病PRV
BioPharma Dive精选评分4040 Halozyme prevails in patent fight with Merck; Enliven readies anticipated leukemia trial
BioPharma Dive评分6565 Caribou to halt CAR-T work, lay off staff amid ‘challenging’ funding climate
STAT News精选评分5353 STAT+: Merck suffers a setback in Europe over its new Keytruda formulation
STAT News评分3838 STAT+: Forbion raises $2.6 billion, its largest fundraise to date
BioSpace精选评分6969 Biotech VC Forbion raises record $2.6B to support 30 ‘high-potential’ companies
STAT News评分3838 STAT+: Pharmalittle: We’re reading about WHO obesity guidelines for kids, DOJ targeting pharma, and more
中文产业新闻精选Chinese source评分7070 艾伯维约109亿美元收购Apogee Therapeutics，获得IL-13单抗zumilokibart等后期管线
中文产业新闻Chinese source评分4040 OpenAI基金会正式启动，要花250亿美元做科研：第一笔钱投向了癌症疫苗、阿尔茨海默和血脑屏障研究
BioSpace精选评分4949 Bayer commits $2.2B to build pharma manufacturing plant in Ohio
BioSpace精选评分6767 Doudna’s CAR T biotech Caribou to end R&D activities, slash staff as financing freezes up
监管与产业动态评分2020 CAR-T biotech Caribou makes ‘heartbreaking’ call to shrink headcount, halt pipeline - Fierce Biotech
BioSpace评分4040 Genmab and AbbVie’s Epkinly win, a rush of deals, Sarepta’s turnaround hopes, more
STAT News评分6262 STAT+: Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down